Описание

Microbiota composition data from stool samples are compared between synbiotic and placebo groups at study endpoint.

Figure 18

Chart

Source Paper

The Effectiveness of Synbiotic Preparation Containing Lactobacillus and Bifidobacterium Probiotic Strains and Short Chain Fructooligosaccharides in Patients with Diarrhea Predominant …

Nutrients (2020)

PMID: 32635661

DOI: 10.3390/nu12071999

Cite This Figure

![Figure 18: Microbiota composition data from stool samples are compared between synbiotic and placebo groups at study endpoint.]()

> Source: Barbara Skrzydło-Radomańska et al. "The Effectiveness of Synbiotic Preparation Containing Lactobacillus and Bifidoba." *Nutrients*, 2020. PMID: [32635661](https://pubmed.ncbi.nlm.nih.gov/32635661/)

<figure>
  <img src="" alt="Microbiota composition data from stool samples are compared between synbiotic and placebo groups at study endpoint." />
  <figcaption>Figure 18. Microbiota composition data from stool samples are compared between synbiotic and placebo groups at study endpoint.<br>  Source: Barbara Skrzydło-Radomańska et al. "The Effectiveness of Synbiotic Preparation Containing Lactobacillus and Bifidoba." <em>Nutrients</em>, 2020. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/32635661/">32635661</a></figcaption>
</figure>

Связанные доказательства

Bifidobacterium longum для Irritable Bowel Syndrome (IBS)

Оценка B · 4 исследований

Galactooligosaccharides (GOS) для Irritable Bowel Syndrome (IBS)

Оценка B · 3 исследований

Lactobacillus acidophilus для Irritable Bowel Syndrome (IBS)

Оценка B · 3 исследований

Fructooligosaccharides (FOS) для Irritable Bowel Syndrome (IBS)

Оценка D · 2 исследований